Hikma Pharmaceuticals covers government's fuel subsidies for its employees
- Jordan: Saturday, November 24 - 2012 at 12:01
- PRESS RELEASE
Hikma Pharmaceuticals announced that it will be covering the costs of the government's monetary compensation of fuel, by providing cash payments to Hikma employees who meet the compensation requirements set forth by the government's mandate to lift fuel subsidies.
Dr. Samih Darwazah, Chairman of the Board of Directors, said, "We feel it is our duty to support the government and do our part in alleviating the financial burden on the Treasury; we also believe in lending a helping hand to our employees and supporting them in living a good quality life."
Hikma Pharmaceuticals is a fast growing multinational group focused on developing, manufacturing and marketing a broad range of both branded and non branded generic and in-licensed products.
Hikma's operations are conducted through three businesses: "Branded", "Injectables" and "Generics" based principally in the MENA region, where it is a market leader, the United States and Europe.
In 2011, Hikma achieved revenues of $918.0m and profit attributable to shareholders of $80.1m.
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / 4C. AME Info FZ LLC / 4C is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.